Next Article in Journal
A Dual Therapy of Nanostructured Lipid Carrier Loaded with Teriflunomide—A Dihydro-Orotate Dehydrogenase Inhibitor and an miR-155-Antagomir in Cuprizone-Induced C57BL/6J Mouse
Next Article in Special Issue
Natural and Synthetic Clay Minerals in the Pharmaceutical and Biomedical Fields
Previous Article in Journal
Clinical Relevance of Targeted Therapy and Immune-Checkpoint Inhibition in Lung Cancer
Previous Article in Special Issue
Antioxidant Efficacy and “In Vivo” Safety of a Bentonite/Vitamin C Hybrid
 
 
Article

Article Versions Notes

Pharmaceutics 2023, 15(4), 1253; https://doi.org/10.3390/pharmaceutics15041253
Action Date Notes Link
article xml file uploaded 16 April 2023 11:23 CEST Original file -
article xml uploaded. 16 April 2023 11:23 CEST Update https://www.mdpi.com/1999-4923/15/4/1253/xml
article pdf uploaded. 16 April 2023 11:23 CEST Version of Record https://www.mdpi.com/1999-4923/15/4/1253/pdf
article html file updated 16 April 2023 11:24 CEST Original file https://www.mdpi.com/1999-4923/15/4/1253/html
Back to TopTop